Highlights from ACR Convergence 2023
View American College of Rheumatology educational opportunities here - https://rheumatology.org/events-programs
ACR Convergence 2023 Highlights: Bimekizumab in Active AS: 5 Year Study
By
RheumNow
FEATURING
Atul Deodhar
By
RheumNow
FEATURING
Atul Deodhar
The above content is not sponsored by, nor part of, the American College of Rheumatology.
Comments 0
Login to view comments.
Click here to Login
